Article Details

Pfizer's bowel disease drug succeeds in late-stage study | Reuters

Retrieved on: 2022-03-24 06:46:38

Tags for this article:

Click the tags to see associated articles and topics

Pfizer's bowel disease drug succeeds in late-stage study | Reuters. View article details on hiswai:

Excerpt

Pfizer Inc said on Wednesday its experimental treatment for an inflammatory bowel disease, acquired last year as part of its $6.7 billion deal for ...

Article found on: www.reuters.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up